MinoxiMed LLC Launches Anti Hair Loss Product for Male

MinoxiMed LLC Launches Anti Hair Loss Product for Male
Middleton, MA, January 18, 2018 --(PR.com)-- Male hair loss, or alopecia as medicians call it, usually does not signal a medical problem. And usually it doesn't harm one's health. But it does cause men worry about how it affects their look. Scientifically speaking, аlopecia is a hair-loss condition which usually affects the scalp. It can be observed in both genders, but it is more common in men. Alopecia is an autoimmune disorder, in which the immune system attacks hair follicles, thus causing hair loss.

According to statistics (http://www.americanhairloss.org/men_hair_loss/introduction.asp), alopecia (also known as male pattern baldness) accounts for more than 95% of hair loss in men. By the age of 32 two-thirds of American men experience some degree of appreciable hair loss, and by the age of fifty approximately 85% of men have significantly thinning hair. In significantly high percentage of men (25%), the process begin prior they reach 21 years of age.

Male pattern baldness can not be treated at 100%, but it can be significantly slowed down with certain remedies, which are available both by prescription and over-the-counter. MinoxiMed is a kind of non-prescription supplement, recently manufactured by MinoxiMed LLC. This is a liquid hair growth product for scalp and beard, intended to rejuvenate the hair growth process. Тhe product is intended for use by men over 18 years of age.

MinoxiMed is already available for purchase in some Asian countries including Thailand, Philippines, Vietnam, Taiwan, Indonesia and Malaysia.
MinoxiMed LLC
Simon Legrand